Delivery Order SPE2DB24D2013-SPE2DB25FCHZJ
- Not listed
- The Defense Logistics Agency awarded a $4,992.08 delivery order to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 17, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,050.78 under firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $10,014.11 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of June 2, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $14,738.91. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance completion targeted for August 7, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $16,119.96 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,252.20 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $9,681.88 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $21,731.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location. This delivery order represents a competitive procurement action under the company's...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCHZJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $7,657.16. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle that runs through December 2026. This IDC enables AmerisourceBergen to serve military healthcare systems, the Defense Health Agency, the U.S. Coast Guard, and other federal medical programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and a critical vendor for federal medical procurement. The company maintains an extensive portfolio of pharmaceutical products and medical supplies for the federal government, including diabetes medications, specialty therapeutics, vaccines, and medical devices across multiple therapeutic areas. The place of performance for this delivery order is AmerisourceBergen's corporate office location in Conshohocken, with an ultimate completion date of April 25, 2025, reflecting the time-sensitive nature of pharmaceutical supply delivery to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 4/24/25 |